Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NYSE:AGL NASDAQ:CELC NASDAQ:LFST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$113.10-2.2%$112.13$88.96▼$136.72$2.12B0.85181,826 shs117,326 shsAGLAgilon Health$1.21-5.1%$1.72$0.71▼$6.08$530.46M0.1122.81 million shs4.45 million shsCELCCelcuity$54.20+1.2%$32.60$7.57▼$55.44$2.17B0.72986,042 shs397,079 shsLFSTLifeStance Health Group$5.49-2.5%$4.75$3.74▼$8.61$2.13B1.173.12 million shs2.04 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-2.22%-2.08%+5.74%+0.84%-13.01%AGLAgilon Health-5.49%-7.66%-33.61%-42.51%-68.66%CELCCelcuity+1.16%+8.49%+25.67%+360.10%+246.99%LFSTLifeStance Health Group-2.49%0.00%+40.77%-7.42%-15.41%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.8154 of 5 stars3.52.00.05.02.22.53.1AGLAgilon Health2.6946 of 5 stars4.12.00.00.03.10.00.6CELCCelcuity0.9718 of 5 stars1.51.00.00.03.13.30.0LFSTLifeStance Health Group3.4819 of 5 stars3.44.00.00.03.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.00Buy$138.8922.80% UpsideAGLAgilon Health 2.11Hold$3.07154.89% UpsideCELCCelcuity 3.00Buy$56.504.24% UpsideLFSTLifeStance Health Group 2.86Moderate Buy$8.5054.83% UpsideCurrent Analyst Ratings BreakdownLatest AGL, ADUS, LFST, and CELC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025ADUSAddus HomeCareStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$140.009/2/2025ADUSAddus HomeCareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$145.008/22/2025ADUSAddus HomeCareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$133.00 ➝ $134.008/20/2025AGLAgilon HealthSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$4.00 ➝ $1.408/19/2025ADUSAddus HomeCareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$83.00 ➝ $109.008/18/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$50.00 ➝ $66.008/15/2025AGLAgilon HealthJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$2.40 ➝ $1.108/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$74.00 ➝ $70.008/14/2025AGLAgilon HealthRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$5.00 ➝ $1.008/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $9.008/6/2025ADUSAddus HomeCareTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$135.00 ➝ $139.00(Data available from 9/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.81$5.29 per share21.37$55.44 per share2.04AGLAgilon Health$6.06B0.08N/AN/A$0.99 per share1.22CELCCelcuityN/AN/AN/AN/A$1.05 per shareN/ALFSTLifeStance Health Group$1.25B1.71$0.04 per share138.20$3.79 per share1.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.5324.9721.101.756.51%9.39%6.86%11/3/2025 (Estimated)AGLAgilon Health-$260.15M-$0.77N/AN/AN/A-5.35%-66.76%-17.47%11/6/2025 (Estimated)CELCCelcuity-$111.78M-$3.45N/AN/AN/AN/A-150.07%-64.67%11/13/2025 (Estimated)LFSTLifeStance Health Group-$57.44M-$0.05N/AN/AN/A-1.23%-1.11%-0.76%11/6/2025 (Estimated)Latest AGL, ADUS, LFST, and CELC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CELCCelcuity-$0.90-$1.04-$0.14-$1.04N/AN/A8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million8/4/2025Q2 2025ADUSAddus HomeCare$1.45$1.49+$0.04$1.20$345.71 million$349.44 million8/4/2025Q2 2025AGLAgilon Health-$0.11-$0.25-$0.14-$0.25$1.47 billion$1.39 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAGLAgilon HealthN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.171.741.74AGLAgilon HealthN/A1.161.16CELCCelcuity2.244.584.58LFSTLifeStance Health Group0.191.481.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AGLAgilon HealthN/ACELCCelcuity63.33%LFSTLifeStance Health Group85.50%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.50%AGLAgilon Health3.57%CELCCelcuity15.78%LFSTLifeStance Health Group6.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.43 million17.60 millionOptionableAGLAgilon Health650414.42 million399.63 millionNot OptionableCELCCelcuity4042.43 million35.73 millionOptionableLFSTLifeStance Health Group10,218388.94 million363.27 millionOptionableAGL, ADUS, LFST, and CELC HeadlinesRecent News About These CompaniesAnalysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.50September 3 at 2:11 AM | americanbankingnews.comRussell Investments Group Ltd. Has $546,000 Position in LifeStance Health Group, Inc. $LFSTSeptember 2 at 3:52 AM | marketbeat.comLifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Rating of "Moderate Buy" by AnalystsSeptember 1 at 2:09 AM | marketbeat.comLandscape Capital Management L.L.C. Takes Position in LifeStance Health Group, Inc. $LFSTAugust 30, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Position in LifeStance Health Group, Inc. $LFSTAugust 29, 2025 | marketbeat.comAlphaQuest LLC Increases Stock Holdings in LifeStance Health Group, Inc. $LFSTAugust 27, 2025 | marketbeat.comWellington Management Group LLP Buys 123,056 Shares of LifeStance Health Group, Inc. $LFSTAugust 27, 2025 | marketbeat.comNuveen LLC Invests $6.93 Million in LifeStance Health Group, Inc. $LFSTAugust 27, 2025 | marketbeat.comLifeStance to Present at the 23rd Annual Morgan Stanley Healthcare ConferenceAugust 26, 2025 | globenewswire.comVanguard Group Inc. Boosts Holdings in LifeStance Health Group, Inc. $LFSTAugust 26, 2025 | marketbeat.comSarah Personette Joins Lifestance Health BoardAugust 22, 2025 | msn.comSarah Personette Appointed to LifeStance Board of DirectorsAugust 22, 2025 | prnewswire.comEntryPoint Capital LLC Buys 55,382 Shares of LifeStance Health Group, Inc. $LFSTAugust 22, 2025 | marketbeat.comInsider Selling: LifeStance Health Group (NASDAQ:LFST) Major Shareholder Sells 3,592,357 Shares of StockAugust 21, 2025 | insidertrades.comVersor Investments LP Boosts Stake in LifeStance Health Group, Inc. $LFSTAugust 20, 2025 | marketbeat.comLifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician ExpansionAugust 18, 2025 | finance.yahoo.comLifeStance Health Group (NASDAQ:LFST) Trading 4.5% Higher - Here's WhyAugust 16, 2025 | marketbeat.comLifeStance Health Group (NASDAQ:LFST) Shares Gap Up - Should You Buy?August 15, 2025 | marketbeat.comLifeStance (LFST) Extends 4-Day Run on Strong EarningsAugust 14, 2025 | finance.yahoo.comLifeStance Health’s Earnings Call Highlights Robust GrowthAugust 13, 2025 | msn.comLifeStance Health Group (NASDAQ:LFST) Raised to Buy at Wall Street ZenAugust 10, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAGL, ADUS, LFST, and CELC Company DescriptionsAddus HomeCare NASDAQ:ADUS$113.10 -2.57 (-2.22%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$113.50 +0.40 (+0.35%) As of 05:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Agilon Health NYSE:AGL$1.20 -0.07 (-5.12%) Closing price 09/3/2025 03:59 PM EasternExtended Trading$1.20 -0.01 (-0.41%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Celcuity NASDAQ:CELC$54.20 +0.62 (+1.16%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$55.23 +1.03 (+1.89%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.LifeStance Health Group NASDAQ:LFST$5.49 -0.14 (-2.49%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$5.49 0.00 (0.00%) As of 09/3/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season IREN Is Up 186% YTD on AI Pivot—And It’s Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
